SCHEMBL2018539

SCHEMBL2018539

C=CC(O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL19949755 0.87 FFAR3 (0.35)
SCHEMBL16186778 0.72
SCHEMBL5476415 0.72
SCHEMBL30800 0.72
SCHEMBL22562174 0.69
SCHEMBL9009578 0.69
Ammonia Solution, Strong SCHEMBL10428699 0.69
SCHEMBL6265101 0.69
SCHEMBL15229311 0.69
SCHEMBL686433 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240150943-A1 NONWOVEN GLUCAN WEBS NUTRITION & BIOSCIENCES USA 4 INC (US) 2024-05-09 US disclosed
US-11802356-B2 Nonwoven glucan webs Nutrition & Biosciences USA 4, Inc. (US) 2023-10-31 US disclosed
CN-113548965-B Preparation method of 1,4 eneyne compound 南京工业大学 2022-07-26 CN disclosed
US-11229611-B2 Clobazam transdermal delivery system and uses thereof TAHO PHARMACEUTICALS LTD. (TW) 2022-01-25 US disclosed
WO-2021222009-A1 CLOBAZAM TRANSDERMAL DELIVERY SYSTEM AND USES THEREOF TAHO PHARMACEUTICALS LTD. (TW) 2021-11-04 WO disclosed
US-20210338600-A1 CLOBAZAM TRANSDERMAL DELIVERY SYSTEM AND USES THEREOF TAHO PHARMACEUTICALS LTD. (TW) 2021-11-04 US disclosed
CN-113548965-A Preparation method of 1, 4-eneyne compound 南京工业大学 2021-10-26 CN disclosed
US-10895028-B2 Nonwoven glucan webs DUPONT INDUSTRIAL BIOSCIENCES USA, LLC (US) 2021-01-19 US disclosed
US-20200338012-A1 APIXABAN TRANSDERMAL DELIVERY SYSTEM AND USES THEREOF TAHO PHARMACEUTICALS LTD (TW) 2020-10-29 US disclosed
WO-2020219384-A1 APIXABAN TRANSDERMAL DELIVERY SYSTEM AND USES THEREOF TAHO PHARMACEUTICALS LTD. (TW) 2020-10-29 WO disclosed
WO-2009026135-A2 CONTROLLED TRANSDERMAL BISOPROLOL DELIVERY SYSTEM ALZA CORPORATION (US) 2009-02-26 WO disclosed
WO-2009026133-A2 TRANSDERMAL BISOPROLOL DELIVERY SYSTEM ALZA CORPORATION (US) 2009-02-26 WO disclosed
US-20040181094-A1 Transition metal oxo complexes as catalysts of synthetic processes involving alkyne reactants REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE 2004-09-16 US disclosed
US-6780953-B2 ACRYLIC POLYMER PARTICULARLY USEFUL IN A SUBMICROLITHOGRAPHIC PROCESS USING KRF (248 NM) OR ARF (193 NM) LASERS AS LIGHT SOURCE HYUNDAI ELECTRONICS INDUSTRIES CO., LTD. (KR) 2004-08-24 US disclosed
US-20030118736-A1 Organic polymer for anti-reflective coating layer and preparation thereof HYUNDAI ELECTRONICS INDUSTRIES CO., LTD. (KR) 2003-06-26 US disclosed
US-20010043992-A1 Organic polymer for anti-reflective coating layer and preparation thereof HYUNDAI ELECTRONICS INDUSTRIES CO., LTD. (KR) 2001-11-22 US disclosed
US-6018050-A ENANTIOMERICALLY PURE COMPOUNDS OBTAINED IN HIGH YIELDS; PREPARING STERICALLY DEMANDING AMINO ACIDS AND THEIR DERIVATIVES, SUCH AS THE PREPARATION OF CIS-4-HYDROXYPROLINE PRECURSORS; ASYMMETRIC SYNTHESIS DEGUSSA AKTIENGESELLSCHAFT (DE) 2000-01-25 US disclosed
EP-0854857-A1 METHOD OF PREPARING OPTICALLY ACTIVE $g(a)-AMINO ACIDS AND $g(a)-AMINO ACID DERIVATIVES DEGUSSA AG (DE) 1998-07-29 EP disclosed
WO-1997010203-A1 METHOD OF PREPARING OPTICALLY ACTIVE α-AMINO ACIDS AND α-AMINO ACID DERIVATIVES DEGUSSA AKTIENGESELLSCHAFT (DE) 1997-03-20 WO disclosed
US-4028234-A HYDROXY-SUBSTITUTED AMINES, ION EXCHANGE RESINS AEROJET-GENERAL CORPORATION (US) 1977-06-07 US disclosed